Insider tradingForm 4
AgomAb Therapeutics NV (AGMB) Insider Trading
7 open-market trades reported since Oct 7, 2026: 7 purchases worth $400K and 0 sales worth $0.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| David R. Epstein | Director | 4 | $220K | 0 | $0 |
| Pierre Thadee Victor Kemula | CFO | 1 | $86K | 0 | $0 |
| Tim Jasper Knotnerus | CEO | 2 | $94K | 0 | $0 |
ADVERTISEMENT
320 × 100 ad slot
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 22 | David R. EpsteinDirector | ▲ BUY | $89K | |
| Oct 9 | David R. EpsteinDirector | ▲ BUY | $45K | |
| Oct 7 | Pierre Thadee Victor KemulaCFO | ▲ BUY | $86K | |
| Oct 7 | Tim Jasper KnotnerusCEO | ▲ BUY | $51K | |
| Oct 7 | David R. EpsteinDirector | ▲ BUY | $44K | |
| Oct 7 | Tim Jasper KnotnerusCEO | ▲ BUY | $44K | |
| Oct 7 | David R. EpsteinDirector | ▲ BUY | $43K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings